• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Contact Us
  • About Towleroad
  • Towleroad on Social Media
  • Privacy Policy

Towleroad Gay News

Gay Blog Towleroad: More than gay news | gay men

  • Travel
  • Sports
  • Law/Justice
  • Celebrities
  • Republicans
  • Madonna
  • Books
  • Men
  • Trans Rights
  • Royals
  • Monkeypox
  • Murray Bartlett and Nick Offerman’s gay relationship ‘The Last of Us’ (Ep 3) will be 2023’s memorable TV moment
  • Many self-identified heterosexuals report feeling attracted toward individuals of the same sex, study finds
  • Taylor Lautner thought Kanye West’s interruption of Taylor Swift’s speech was planned

Pfizer says COVID-19 pill near 90% effective in final analysis

Towleroad December 14, 2021 Leave a Comment

Published by
Reuters
471011 origin 1

By Michael Erman and Deena Beasley

NEW YORK (Reuters) -Pfizer Inc on Tuesday said final analysis of its antiviral COVID-19 pill still showed near 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the fast spreading Omicron variant of the coronavirus.

The U.S. drugmaker last month said the oral medicine was around 89% effective in preventing hospitalizations or deaths when compared to placebo, based on interim results in around 1,200 people. The data disclosed on Tuesday includes an additional 1,000 people.

Nobody in the trial who received the Pfizer treatment died, compared with 12 deaths among placebo recipients.

The Pfizer pills are taken with the older antiviral ritonavir every 12 hours for five days beginning shortly after onset of symptoms. If authorized, the treatment will be sold as Paxlovid.

“It’s a stunning outcome,” Pfizer Chief Scientific Officer Mikael Dolsten said in an interview.

“We’re talking about a staggering number of lives saved and hospitalizations prevented. And of course, if you deploy this quickly after infection, we are likely to reduce transmission dramatically,” Dolsten said.

Pfizer also released early data from a second clinical trial suggesting that the treatment reduced hospitalizations by around 70% in a smaller trial of standard-risk adults, including some higher-risk vaccinated people. The results were not statistically significant, but Pfizer said they showed a “positive data trend for reduction in risk.”The trial did not show that the drug alleviated symptoms of COVID-19 in the same population.

The results in standard-risk individuals are from interim analyses at 60% and 80% of enrollment of the now fully-enrolled trial of over 1,100 people. Pfizer will continue the trial and release more data when its done.

Dolsten said he expects authorization for use in high-risk individuals from the U.S. Food and Drug Administration and other regulatory agencies soon. He does not believe an FDA advisory panel meeting will be needed.

“We’re in very advanced regulatory dialogues with both Europe and the UK, and we have dialogues with most of the major regulatory agencies globally,” Dolsten said.

Pfizer submitted data to the U.S. FDA last month, asking for emergency use authorization of the drug.

The FDA’s decision could come within a matter of weeks, if not days, said Zarina Saidova, an analyst at Moscow-based Finam Holdings, as the new data confirms what the company previously disclosed and submitted to the regulator.

Saidova expects Paxlovid to generate $15 billion to $20 billion in revenue next year, a significant boost for the company in the face of a potential decline in vaccine sales.

There are currently no oral antiviral treatments for COVID-9 authorized in the United States.

Rival Merck & Co has asked for emergency use authorization of its antiviral pill molnupiravir. But that drug only reduced hospitalizations and deaths in its clinical trial of high-risk patients by around 30%.

Some scientists have also raised safety concerns about the potential for birth defects from the Merck drug, as well as worries that it could cause the virus to mutate.

Pfizer’s drug works differently. It is part of a class of drugs called protease inhibitors currently used to treat HIV, hepatitis C and other viruses.

Pfizer shares fell 0.8% to $54.75 in trading before the bell, while Merck shares were flat at $72.69.

Dolsten said recent laboratory testing showed that activity against the protease of the Omicron variant is as “good as basically any SARS-COV-2 variant of concern.”

The company has said it can have 180,000 treatment courses ready to ship this year and plans to produce at least 80 million more in 2022.

Dolsten said Pfizer is looking to expand that output further as new variants, like the newly-discovered Omicron, could push the need for antivirals substantially higher. Current vaccines appear to be less effective at preventing infection with Omicron.

Pfizer, which makes one of the leading COVID-19 vaccines with German partner BioNTech, has agreed to allow generic manufacturers to supply versions of the drug to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP). However, Dolsten said that for next year he expects the drug will be mainly produced by Pfizer.

The U.S. government has already secured 10 million courses of the Pfizer drug for $5.29 billion.

(Reporting by Michael Erman in New Jersey and Deena Beasley in Los Angeles, Additional reporting by Mrinalika Roy; Editing by Bill Berkrot, Anil D’Silva and Nick Zieminski)

Topics: Aaon, towleroad

  • Many self-identified heterosexuals report feeling attracted toward individuals of the same sex, study finds

    Many self-identified heterosexuals report feeling attracted toward individuals of the same sex, study finds

    Published by PsyPost Sexuality is commonly thought to be a spectrum. If that is true, is anyone fully straight? Does that blur the label of what heterosexual means? A study published in Archives of Sexual Behavior …Read More »
  • Taylor Lautner thought Kanye West’s interruption of Taylor Swift’s speech was planned

    Taylor Lautner thought Kanye West’s interruption of Taylor Swift’s speech was planned

    Published by BANG Showbiz English Taylor Lautner thought it was part of a planned “skit” when Kanye West interrupted Taylor Swift’s MTV Video Music Awards (VMAs) acceptance speech. The ‘Twilight’ actor presented the Best Female Video …Read More »
  • How to Get Tickets to Beyonce’s Renaissance World Tour

    How to Get Tickets to Beyonce’s Renaissance World Tour

    Published by PopCrush Wondering how to get tickets to Beyoncé‘s Renaissance World Tour? We’ve got you covered. Queen Bey will hit the road in May to bring her next iconic tour to the BeyHive. Beyoncé announced …Read More »
  • U.S. African American studies does not include material targeted by Florida governor

    U.S. African American studies does not include material targeted by Florida governor

    Published by Reuters By Brad Brooks (Reuters) – An African American studies course for U.S. high school students that was released on Wednesday does not include material that Florida’s conservative governor said pushed a liberal agenda, …Read More »
Previous Post: « J.K. Rowling Accused Of Having ‘Unhealthy Fixation’ On Transgender Community After Trashing Cops For Labeling Rapists As ‘Women’
Next Post: Elon Musk wants to take a ‘futuristic Noah’s ark’ to Mars »

Primary Sidebar

Adjacent News

  • Why cops kill: A Q&A with policing expert Dr. DeLacy Davis

    Why cops kill: A Q&A with policing expert Dr. DeLacy Davis

  • Rep. George Santos vows to stop lying : ‘I’ve learned my lesson’

    Rep. George Santos vows to stop lying : ‘I’ve learned my lesson’

  • George Santos campaign made suspicious payments to Miami Beach parking lot

    George Santos campaign made suspicious payments to Miami Beach parking lot

Good Trash: Going to Read It Somewhere, Y'know

  • Dennis Rodman On If He’d Ever Get Back With Ex-Girlfriends: “I Tried Madonna, I Tried Carmen Electra…”

    Dennis Rodman On If He’d Ever Get Back With Ex-Girlfriends: “I Tried Madonna, I Tried Carmen Electra…”

  • James Gunn Seemingly Confirms The DCU Will Finally Have Gay Superheroes

    James Gunn Seemingly Confirms The DCU Will Finally Have Gay Superheroes

  • Vanilla Ice Admits He Rejected Madonna’s Proposal Before They Split: ‘I Thought The Guy Was Supposed To Do That’

    Vanilla Ice Admits He Rejected Madonna’s Proposal Before They Split: ‘I Thought The Guy Was Supposed To Do That’

RSS Partner Links

  • Snapped! Jonathan Groff and Ben Aldridge on red carpet at premiere of thriller “Knock At The Cabin”
  • Emma Roberts & Ashley Benson Spotted on a Double Date!
  • Putting Marge On A Committee Goes As Well As Expected
  • Night Crumbs
  • Portia de Rossi Surprised Wife Ellen DeGeneres With A Vow Renewal Ceremony Officiated By Kris Jenner
  • Hot Slut Of The Day!
  • Open Post: Hosted By Madonna Doing The “Wednesday Dance” To Lady Gaga’s Song

Most Recent

  • Murray Bartlett and Nick Offerman’s gay relationship ‘The Last of Us’ (Ep 3) will be  2023’s memorable TV moment

    Murray Bartlett and Nick Offerman’s gay relationship ‘The Last of Us’ (Ep 3) will be 2023’s memorable TV moment

  • Many self-identified heterosexuals report feeling attracted toward individuals of the same sex, study finds

    Many self-identified heterosexuals report feeling attracted toward individuals of the same sex, study finds

  • Taylor Lautner thought Kanye West’s interruption of Taylor Swift’s speech was planned

    Taylor Lautner thought Kanye West’s interruption of Taylor Swift’s speech was planned

  • How to Get Tickets to Beyonce’s Renaissance World Tour

    How to Get Tickets to Beyonce’s Renaissance World Tour

  • U.S. African American studies does not include material targeted by Florida governor

    U.S. African American studies does not include material targeted by Florida governor

  • ‘Sister Wives’ Alum Gwendlyn Brown Claims She Was ‘Disappointed’ TLC Tried To ‘Exploit’ Her Bisexuality

    ‘Sister Wives’ Alum Gwendlyn Brown Claims She Was ‘Disappointed’ TLC Tried To ‘Exploit’ Her Bisexuality

  • Trump outlines plan to attack trans rights if re-elected, vows to ‘protect children from left-wing gender insanity’

    Trump outlines plan to attack trans rights if re-elected, vows to ‘protect children from left-wing gender insanity’

  • Finn Wolfhard ‘really proud’ of Noah Schnapp for coming out as gay

    Finn Wolfhard ‘really proud’ of Noah Schnapp for coming out as gay

Most Commented

Social

Twitter @tlrd | Facebook | Instagram @tlrd

Footer

Copyright © 2023 · Log in

×